Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 3, August

Biological Basis of Novel Therapies for Myelodysplastic Syndrome

Volume:2   Issue: 3
Pp: 199-209
Eyal C. Attar and Karen K. Ballen
DOI: 10.2174/157339406777934708
Published on: 01 March, 2012

Current Treatment of Relapsed Ovarian Carcinoma

Volume:2   Issue: 3
Pp: 211-221
Aristotle Bamias, Alexandros Rodolakis and Meletios A. Dimopoulos
DOI: 10.2174/157339406777934726
Published on: 01 March, 2012

Lenalidomide: Cancer Therapy via Antiangiogenesis and Immunomodulation

Volume:2   Issue: 3
Pp: 223-229
Tanyifor M. Tohny, Jurgen Venitz, Alex Sparreboom and William D. Figg
DOI: 10.2174/157339406777934690
Published on: 01 March, 2012

A Role for Tumor Suppressor Protein p53 in the Fidelity of DNA Synthesis and Resistance Towards Nucleoside Analogs

Volume:2   Issue: 3
Pp: 231-241
Mary Bakhanashvili and Galia Rahav
DOI: 10.2174/157339406777934672
Published on: 01 March, 2012

Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis

Volume:2   Issue: 3
Pp: 243-253
Gajanan V. Sherbet
DOI: 10.2174/157339406777934735
Published on: 01 March, 2012

Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells

Volume:2   Issue: 3
Pp: 255-270
Caryl J. Giuliano, Sarah J. Freemantle and Michael J. Spinella
DOI: 10.2174/157339406777934681
Published on: 01 March, 2012

Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy

Volume:2   Issue: 3
Pp: 271-279
Yong Wang, Virginia Probin and Daohong Zhou
DOI: 10.2174/157339406777934717
Published on: 01 March, 2012